PubMed Result FiltersSupplemental ContentSimple NCBI Directory

more...











Warning:
The NCBI web site requires JavaScript to function.
more...






My NCBISign in to NCBISign Out

















  • Format: Abstract
Format























Send to
jQuery(document).ready( function ()
jQuery("#send_to_menu input[type='radio']").click( function ()
var selectedValue = jQuery(this).val().toLowerCase();
var selectedDiv = jQuery("#send_to_menu div." + selectedValue);

if(selectedDiv.is(":hidden"))
jQuery("#send_to_menu div.submenu:visible").slideUp();
selectedDiv.slideDown();

);

);

jQuery("#sendto").bind("ncbipopperclose", function()
jQuery("#send_to_menu div.submenu:visible").css("display","none");
jQuery("#send_to_menu input[type='radio']:checked").attr("checked",false);
);




Choose Destination
























































J Med Chem. 2000 Oct 5;43(20):3714-7.

Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.



Ertl P1, Rohde B, Selzer P.


Author information


1

Cheminformatics, Novartis Pharma AG, WKL-490.4.35, CH-4002 Basel, Switzerland. peter.ertl@pharma.novartis.com



Abstract


Molecular polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive molecular transport through membranes and, therefore, allows prediction of transport properties of drugs. The calculation of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D molecular geometry and the calculation of the surface itself. A new approach for the calculation of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments. The method, termed topological PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coefficient between 3D PSA and fragment-based TPSA for 34 810 molecules from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster. The new methodology may, therefore, be used for fast bioavailability screening of virtual libraries having millions of molecules. This article describes the new methodology and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.




PMID:
11020286

[Indexed for MEDLINE]


Share





MeSH terms, Substance



MeSH terms


  • Biological Availability

  • Biological Transport

  • Models, Molecular

  • Molecular Structure*

  • Pharmaceutical Preparations/chemistry*

  • Pharmaceutical Preparations/metabolism

  • Reproducibility of Results

Substance


  • Pharmaceutical Preparations




LinkOut - more resources



Full Text Sources


  • American Chemical Society

Other Literature Sources


  • Cited by Patents in - The Lens

Medical


  • Medicines - MedlinePlus Health Information

Miscellaneous


  • NCI CPTAC Assay Portal

  • NCI CPTC Antibody Characterization Program
















Supplemental Content






Full text links


Icon for American Chemical Society



<!-- -->
Loading ...













Support Center

















Popular posts from this blog

How to make RAID controller rescan devices The 2019 Stack Overflow Developer Survey Results Are InLSI MegaRAID SAS 9261-8i: Disk isn't recognized after replacementHow to monitor the hard disk status behind Dell PERC H710 Raid Controller with CentOS 6?LSI MegaRAID - Recreate missing RAID 1 arrayext. 2-bay USB-Drive with RAID: btrfs RAID vs built-in RAIDInvalid SAS topologyDoes enabling JBOD mode on LSI based controllers affect existing logical disks/arrays?Why is there a shift between the WWN reported from the controller and the Linux system?Optimal RAID 6+0 Setup for 40+ 4TB DisksAccidental SAS cable removal

Unbreakable Formation vs. Cry of the Carnarium The 2019 Stack Overflow Developer Survey Results Are InCan an indestructible creature die by a combination of damage and -X/-X effects?Can a non-instant or sorcery ever have flashback?do creatures created after a “all creatures get -1/-1 until end of turn” instant get -1/-1 as well?What happens when I target an indestructible card with an “if that would die this turn, exile it instead” effect?Exalted trigger timingWhat happens when a non-token creature loses all abilities, is exiled, then returns?Does the spell cast with Yahenni's Expertise resolve before state-based effects are checked?What happens if Always Watching is destroyed mid-combat?MTG: Abilities lost when exiled?Under which controller does a stolen permanent come into play after being exiled?

How can I have a shield and a way of attacking at distance at the same time? The 2019 Stack Overflow Developer Survey Results Are InDoes the Thrown property mean I can attack with my DEX?Is it possible to build a custom weapon, and if so, how will my character be able to use it?Can the Ghost Touch weapon property allow an attacker to perform incorporeal touch attacks?The DM allowed me to wield two shields, how can I get the most AC and HP, as a Bear Barbarian?Are there ways other than Kensei Weapons or Hex Warrior to use an ability other than STR for non-finesse melee weapons?Cheapest way to cast spells with sword and (heavy) shield?Is this homebrew “Throwing Weapons Master” feat balanced?Can Hexblade warlocks use a staff and shield?Are there any balance issues with allowing thrown Javelins to be drawn for free like ammunition weapons?Does an unattuned Frost Brand weapon still glow in freezing temperatures?Does a druid starting with a bow start with no arrows?Is it possible to build a custom weapon, and if so, how will my character be able to use it?